RRMM
BBNX

Regatta Research & Money Management’s Beta Bionics BBNX Stock Holding History

Regatta Research & Money Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$298K Buy
+19,034
New +$226K 0.28% 73

Other funds holding BBNX

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Regatta Research & Money Management's BBNX Position: Q2 2026 in Review

Regatta Research & Money Management opened a new position in Beta Bionics (BBNX) in Q2 2026: 19,034 shares worth $298K. The stake represents 0.28% of the portfolio and ranks #73 among its holdings.

63 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Regatta Research & Money Management held 19,034 shares of Beta Bionics worth $298K as of Q2 2026.
  • Beta Bionics was a new Regatta Research & Money Management position in Q2 2026.
  • Beta Bionics made up 0.28% of Regatta Research & Money Management's portfolio in Q2 2026, its #73 holding.
  • 63 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Regatta Research & Money Management's 13F filing for Q2 2026, filed 12 Aug 2026.